Nanodiamonds for drug delivery and other biomedical applications

E-mail Печать PDF

 4th International Conference Nanobiophysics: Fundamental and Applied Aspects, 1-4 October 2015, Kyiv, Ukraine

 Nanodiamonds for drug delivery and other biomedical applications

O. Gogotsi1, Y. Gogotsi2, V. Mochalin2,  Y. Zozulya1, B. Malinovskiy1, V. Zahorodna1, I. Uvarova3, H. Gogotsi3,

1 Materials Research Centre, 3 Akademika Krzhyzhanovs'koho St, Kyiv 03680, Ukraine, E-mail: Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript
2 A. J. Drexel Nanomaterials Institute, and Department of Materials Science and Engineering, Drexel University, Philadelphia, PA 19104, USA, E-mail: Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript
 3 Frantsevich Institute for Problems of Materials Science of NASU, 3 Akademika Krzhyzhanovs'koho St, Kyiv 03680, Ukraine, E-mail: Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript

Abstract

     Carbon nanomaterials hold tremendous potential in addressing the two major issues faced by our society: providing energy and improving healthcare. Nanodiamond powder produced by detonation synthesis is one of the most promising carbon nanomaterials for drug delivery and theranostics [1], [2]. Diamond particles have a ~4-5 nm stable core and a large surface area with tailorable surface chemistry. Nanodiamonds have unique optical, mechanical and thermal properties. These properties have recently started to attract much interest for different biomedical applications [3]. Rich surface chemistry, nontoxicity and good biocompatibility of diamond nanoparticles make them attractive in biomaterial applications [4].
      The development of new methods for obtaining free nanodiamond particles opens up new possibility for targeted drug-delivery systems that overcome cell membranes, various biological markers, systems intended for determination of the concentration of bioactive agents in living organisms, and others applications [5]. For tissue engineering scaffolds, the non-toxic fluorescent nanodiamond introduced into biodegradable polymers provides increased strength, visual monitoring, and enhanced biomineralization [6].
Nanodiamond (ND) particles are increasingly being utilized as diagnostic, imaging, and therapeutic agents in biomedicine [7]. In the area of biomedical imaging and diagnostics, luminescent nanodiamond with NV centers, as well as chemically modified fluorescent nanodiamond, hold tremendous potential to replace toxic semiconductor quantum dots, thus bringing this exciting potential application one step closer to the clinics [8]. Before nanodiamonds could be applied, they have to undergo multistage purification, characterization and surface modification. Various approaches of surface modification and functionalization of nanodiamond allow to enhance and control drug adsorption for prolongation of drug action and chemical binding of the drugs for sustained drug release for their further use as a drug delivery platform. As for drug delivery, this study mainly focuses on adsorption of antibiotics that will be discussed in detail. We demonstrate results of physical−chemical study of the adsorption of doxorubicin, polymyxin B and rifampicin on nanodiamonds.

References:
 [1]. V. Mochalin, O. Shenderova, D. Ho, Y. Gogotsi The Properties and Applications of Nanodiamonds (Review), Nature Nanotechnology, 7 (1), p.11-23 (2012)
[2]. V. Mochalin, A. Pentecost, X.-M. Li, I. Neitzel, M. Nelson, C. Wei, T. He, F. Guo, Y. Gogotsi Adsorption of Drugs on Nanodiamond: Toward Development of a Drug Delivery Platform, Molecular Pharmaceutics, 10 (10), p.3728-3735 (2013)
[3]. O. Shenderova, D. Gruen, ed. Detonation Nanodiamonds: Science and Applications (2nd Edition), CRC Press (2014)
[4]. Q. Zhang, V. Mochalin, I. Neitzel, I. Knoke, J. Han, C. Klug, J. Zhou, P. Lelkes, Y. Gogotsi, Fluorescent PLLA-nanodiamond composites for bone tissue engineering, Biomaterials, 32 (1), p. 87-94 (2011)
[5]. A. Schrand, S. Hens, O. Shenderova Nanodiamond particles: properties and perspectives for bioapplications, Critical Reviews in Solid State and Materials Sciences, 34(1–2), p. 18–74 (2009)
[6]. Q. Zhang, V. Mochalin, I. Neitzel, K. Hazeli, J. Niu, A. Kontsos, J. G. Zhou, P. I. Lelkes, Y. Gogotsi Multifunctional Nanodiamond-PLLA Scaffolds for Bone Tissue Engineering: Enhanced Mechanical Strength and Biomineralization, Biomaterials, 33 (20), p.5067-5075 (2012)
[7]. V. Vaijayanthimala, D. Lee, S. Kim, A. Yen, D. Tsai, H.-C. Chang, O. Shenderova Nanodiamond-mediated drug delivery and imaging: challenges and opportunities, Expert Opinion on Drug Delivery 12 (6), p. 1-15 (2014)
[8]. G. Balasubramanian, A. Lazariev, S. R. Arumugam, et al. Nitrogen-Vacancy color center in diamond-emerging nanoscale applications in bioimaging and biosensing. Current Opinion in Chemical Biology 20, p. 69-77 (2014)

Download PDF version of Nanodiamonds for drug delivery and other biomedical applications 

Here you can find Book of Abstract of the Conference NBP 2015

 

News from MRC.ORG.UA

Our new collaborative research paper with Drexel team on Porous Ti3AlC2 MAX phase enables efficient synthesis of Ti3C2Tx MXene

porous MAX phase technologyIn this study, we have optimized the synthesis of MAX phases for MXene manufacturing. The main purpose of this study is to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.

 
Novel electrically conductive electrospun PCL‑MXene scaffolds for cardiac tissue regeneration

Scanning electron microscopy image of PCLMXene membranes crosssection (left side) with the representation of EDX line (dotted line) and example of cross-sectional EDX elements line scan (right side)Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.

 
Read recently published paper about our collaborative work: MXene Functionalized Kevlar Yarn via Automated, Continuous Dip Coating

MXene Functionalized Kevlar Yarn via Automated,Continuous Dip CoatingThe rise of the Internet of Things has spurred extensive research on integrating conductive materials into textiles to turn them into sensors, antennas, energy storage devices, and heaters. MXenes, owing to their high electrical conductivity and solution processability, offer an efficient way to add conductivity and electronic functions to textiles. Here, a versatile automated yarn dip coater tailored for producing continuously high-quality MXene-coated yarns and conducted the most comprehensive MXene-yarn dip coating study to date is developed. 

 
MX-MAP project secondment visit of Dr. Oleksiy Gogotsi and Veronika Zahorodna from MRC to University of Padova, Italy, October 2023

altMX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 

 
CanbioSe Project Meeting and Project Workshop, September 26-27, 2023, Montpellier, France

altCanbioSe Project Meeting and Project Workshop was held  at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.

 
IEEE NAP 2023: 2023 IEEE 13th International Conference “Nanomaterials: Applications & Properties” Sep 10, 2023 - Sep 15, 2023, Bratislava, Slovakia

altDr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.

 
Visit to CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA)

altDirector of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.

 
MX-MAP Session at YUCOMAT Conference 2023 "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.

altMX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.

 
THE TWENTY-FOURTH ANNUAL CONFERENCE YUCOMAT 2023, HERCEG NOVI, MONTENEGRO, September 04-08, 2023

altThe conference was organised by the Materials Research Society of Sebia and supported by MRS-Singapore with the participation of a pleiad of distinguished scientists.

 
CANBIOSE secondment visit of Dr. Oleksiy Gogotsi and Veronika Zahorodna from MRC to European Institute of Membranes in Montpellier, France

altCANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.

 
MRC researchers visited Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to CANBIOSE project, April-May 2023

altMRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 

 
Twenty Third Annual Conference - YUCOMAT 2022 Twelfth World Round Table Conference on Sintering - XII WRTCS 2022 Herceg Novi, August 29 – September 2, 2022

alt

Our collaborators and partners  presented our joint research at the Yucomat conference - at Symposium on Biomaterials and two collaborative posters at Conference Poster Session.

 
MRC team visited 2nd international MXene conference "MXenes: Addressing Global Challenges with Innovation"at Drexel University, USA on Aug. 1-3, 2022

second MXene COnference 2022, Drexel University, USA

MRC team members Dr. Oleksiy Gogotsi, Veronika Zahorodna, Dr. Iryna Roslyk visited MXene Confrence 2022.  This 2nd international MXene conference at Drexel University, August 1-3, 2022, put major MXene discoveries, including their record-breaking electrical conductivity, electromagnetic interference shielding capability, electrochemical capacitance, light-to-heat conversion, and other properties, into perspective.

 
Launching HORIZON-MSCA-2021-SE-01 MX-MAP Project: Towards MXenes biomedical applications by high-dimensional immune MAPping

MX-MAP project Meeting during the MXene international conference held in Drexel University on Aug. 3,  2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.

 
H2020-MSCA-RISE NANO2DAY research project, last updates

alt

Researchers from University of Latvia and Materials Research Center, Ukraine are visiting Drexel University due to Horizon-2020-MSCA-RISE NANO2DAY research project.